PHARMACEUTICAL-TRACEABILITY

PHARMACEUTICAL-TRACEABILITY

Data Quality Issues At The Heart Of FDA's DSCSA Troubles

The Struggle for Seamless Pharmaceutical Traceability The Food and Drug Administration (FDA) has recently announced a series of delays and guidelines for the implementation of the Drug Supply Chain Security Act (DSCSA). This move is aimed at addressing the critical issue of data quality, which has been a major hurdle in achieving seamless pharmaceutical traceability..

PHARMACEUTICAL-TRACEABILITY

Pharmaceutical Traceability Market Global Market Trends

Introduction The pharmaceutical industry has long been plagued by issues related to counterfeit drugs, regulatory noncompliance, and supply chain inefficiencies..